Cargando…

Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes

INTRODUCTION: Acne arises during puberty, in part, due to elevated hormones and growth factors which stimulate de novo lipogenesis (DNL) in primary sebocytes to significantly increase sebum production. Oral isotretinoin is an effective acne therapy, reducing sebum production through inducing apoptos...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicoll, James, Buehrer, Benjamin M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048953/
https://www.ncbi.nlm.nih.gov/pubmed/32158247
http://dx.doi.org/10.2147/CCID.S243154
_version_ 1783502371501899776
author Nicoll, James
Buehrer, Benjamin M
author_facet Nicoll, James
Buehrer, Benjamin M
author_sort Nicoll, James
collection PubMed
description INTRODUCTION: Acne arises during puberty, in part, due to elevated hormones and growth factors which stimulate de novo lipogenesis (DNL) in primary sebocytes to significantly increase sebum production. Oral isotretinoin is an effective acne therapy, reducing sebum production through inducing apoptosis in sebocytes. However, isotretinoin is teratogenic and has additional unwanted side effects, including an initial acne flare-up, which limits its utility. The biguanide, metformin has been found to alleviate severe acne in women with polycystic ovary syndrome (PCOS) through normalization of their insulin and androgen hormone levels. Metformin’s broader effectiveness to improve acne in non-PCOS populations lacks significant clinical support. In an effort to determine whether biguanides directly affect sebogenesis, we investigated their ability to alter DNL in cell-based assays in vitro. METHODS: De novo lipogenesis was measured in human primary sebocytes using [14C]-acetate labeling. Lipid species analysis was performed by extracting newly synthesized lipids and subjecting them to thin layer chromatography. Gene expression changes in sebocytes were identified through qPCR analysis of isolated RNA. Metabolic parameters including oxygen consumption rate, lactate production and activation of adenosine monophosphate-dependent protein kinase (AMPK) were assessed in human primary sebocytes. RESULTS: Using human primary sebocytes, we found that biguanides, isotretinoin and azithromycin induced an acute dose and time-dependent increase in [14C]-acetate labeling of neutral lipids, while AICAR, an AMPK activator, inhibited this DNL response. Biguanides did not activate AMPK in sebocytes, however, they significantly reduced oxygen consumption rate and increased lactate production. Treatment with biguanides, but not isotretinoin, significantly upregulated ACSS2 gene expression in primary sebocytes and showed synergism with lipogenic activators to induce DNL genes. DISCUSSION: These changes are consistent with an acute increase in sebocyte lipogenesis and support the potential of biguanides to cause an initial flare-up in patients suffering from severe acne.
format Online
Article
Text
id pubmed-7048953
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70489532020-03-10 Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes Nicoll, James Buehrer, Benjamin M Clin Cosmet Investig Dermatol Original Research INTRODUCTION: Acne arises during puberty, in part, due to elevated hormones and growth factors which stimulate de novo lipogenesis (DNL) in primary sebocytes to significantly increase sebum production. Oral isotretinoin is an effective acne therapy, reducing sebum production through inducing apoptosis in sebocytes. However, isotretinoin is teratogenic and has additional unwanted side effects, including an initial acne flare-up, which limits its utility. The biguanide, metformin has been found to alleviate severe acne in women with polycystic ovary syndrome (PCOS) through normalization of their insulin and androgen hormone levels. Metformin’s broader effectiveness to improve acne in non-PCOS populations lacks significant clinical support. In an effort to determine whether biguanides directly affect sebogenesis, we investigated their ability to alter DNL in cell-based assays in vitro. METHODS: De novo lipogenesis was measured in human primary sebocytes using [14C]-acetate labeling. Lipid species analysis was performed by extracting newly synthesized lipids and subjecting them to thin layer chromatography. Gene expression changes in sebocytes were identified through qPCR analysis of isolated RNA. Metabolic parameters including oxygen consumption rate, lactate production and activation of adenosine monophosphate-dependent protein kinase (AMPK) were assessed in human primary sebocytes. RESULTS: Using human primary sebocytes, we found that biguanides, isotretinoin and azithromycin induced an acute dose and time-dependent increase in [14C]-acetate labeling of neutral lipids, while AICAR, an AMPK activator, inhibited this DNL response. Biguanides did not activate AMPK in sebocytes, however, they significantly reduced oxygen consumption rate and increased lactate production. Treatment with biguanides, but not isotretinoin, significantly upregulated ACSS2 gene expression in primary sebocytes and showed synergism with lipogenic activators to induce DNL genes. DISCUSSION: These changes are consistent with an acute increase in sebocyte lipogenesis and support the potential of biguanides to cause an initial flare-up in patients suffering from severe acne. Dove 2020-02-24 /pmc/articles/PMC7048953/ /pubmed/32158247 http://dx.doi.org/10.2147/CCID.S243154 Text en © 2020 Nicoll and Buehrer. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Nicoll, James
Buehrer, Benjamin M
Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
title Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
title_full Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
title_fullStr Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
title_full_unstemmed Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
title_short Biguanides Induce Acute de novo Lipogenesis in Human Primary Sebocytes
title_sort biguanides induce acute de novo lipogenesis in human primary sebocytes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048953/
https://www.ncbi.nlm.nih.gov/pubmed/32158247
http://dx.doi.org/10.2147/CCID.S243154
work_keys_str_mv AT nicolljames biguanidesinduceacutedenovolipogenesisinhumanprimarysebocytes
AT buehrerbenjaminm biguanidesinduceacutedenovolipogenesisinhumanprimarysebocytes